OTTAWA, March 12 /CNW Telbec/ - Health Canada is warning consumers not to
use Lots GC6038 and GC6052 of the product ReNu MultiPlus contact lens solution
because they contain higher than expected amounts of iron that could reduce
the product's effectiveness and cause serious eye injury from infection. A
recall of the affected lots from wholesalers, retailers, distributors and eye
care professionals has been initiated by the manufacturer, Bausch and Lomb.
ReNu MultiPlus is used for the cleansing, rinsing and storage of soft
contact lenses. Bausch and Lomb has advised Health Canada that it began an
investigation into the product after receiving three customer reports of
discoloured solution. This discolouration is caused by higher than expected
levels of iron, and indicates that the solution may be losing effectiveness.
People who used the affected lots and experience symptoms of eye
infection such as redness, swelling, discharge, pain, itchiness, increased
sensitivity to light or change in vision should seek medical attention.
The affected lots were packaged in ReNu MultiPlus Club Packs and
ReNu MultiPlus Vision Packs, each of which contain two 480 mL bottles of
solution. Lot numbers can usually be found on the front panel of the bottle.
If any bottle of this product has either of the Lot numbers GC6052 or GC6038,
then it is part of this recall and consumers should immediately stop using the
product and either dispose of it or contact the Bausch and Lomb consumer
affairs line (1-888-459-5000) to arrange for a replacement. However, consumers
should not discard these products until they have received guidance from their
Municipal Government regarding their safe disposal. The Drug Identification
Number (DIN) for this product is 02230538. The DIN can be found on the front
panel of the product label and outer packaging.
Health Canada continues to monitor the effectiveness of this recall.
Consumers requiring more information about this advisory can contact
Health Canada's public enquiries line at (613) 957-2991, or toll free
To report a suspected adverse reaction to this or any other health
product, please contact the Canadian Adverse Drug Reaction Monitoring Program
(CADRMP) of Health Canada by one of the following methods:
Marketed Health Products Directorate
Tunney's Pasture, AL 0701C
The CADRMP adverse reaction reporting form, including a version that can
be completed and submitted online, is located on the MedEffect portal
(www.medeffect.gc.ca) of the Health Canada Web site.
Egalement disponible en français
For further information:
For further information: Media Inquiries: Health Canada, (613) 957-2983;
Public Inquiries: (613) 957-2991, 1-866 225-0709